| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e74c4dcce911900cd2b0a96fc5d5e62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec2cf2772a722c89d7cdeaf3f7f441cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_504a2574b73d934951fd3447a56002f6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-344 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2011-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92a4b12d48f6c30ea093ff18a2cbcb12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c97a1c4658a6c30ed3593b0d57ed2c9 |
| publicationDate |
2015-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9125930-B2 |
| titleOfInvention |
EGFR aptamer inhibitor for use in therapy and diagnosis |
| abstract |
The present invention concerns a nucleotide aptamer having the sequence 5′ GCCUUAGUAACGUGCUUUGAUGUCGAUUCGACAGGAGGC3′ (SEQ ID No. 1) for use in the treatment and/or prevention and/or diagnosis of an EGFR induced disorder and a pharmaceutical composition comprising the same. The invention also relates to a method for the diagnosis of a EGFR induced disorder in a patient from which a sample is obtained and relative diagnostic kit. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9410156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9316647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021202858-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014296501-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10544419-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9994857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208663-B2 |
| priorityDate |
2010-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |